Cytotoxicity studies of quercetin, shikimate, cyclohexanecarboxylate and ptaquiloside

Veterinary and Human Toxicology

Volumn 38, Issue 1, 1996, Pages 14-18

  Ngomuo, A J ^a   Jones, R S ^b  

^a SOKOINE UNIVERSITY OF AGRICULTURE   (Tanzania)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; MITOMYCIN C; PLANT TOXIN; PTAQUILOSIDE; QUERCETIN; SHIKIMIC ACID;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL STRAIN 3T3; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; FERN; GROWTH INHIBITION; KIDNEY CELL; MOUSE; NONHUMAN; RAT;

ANIMALS; CELL COUNT; CELL DIVISION; CHO CELLS; CRICETINAE; CRICETULUS; CYCLOHEXANECARBOXYLIC ACIDS; FIBROBLASTS; INDANS; KIDNEY; MICE; MITOMYCIN; PLANT POISONING; QUERCETIN; RATS; SESQUITERPENES; SHIKIMIC ACID; TERPENES;

ANIMALIA; BOS TAURUS; CRICETINAE; CRICETULUS GRISEUS; FILICOPHYTA; PTERIDIUM AQUILINUM;

EID: 0030048488     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Evans WC: The acute diseases caused by bracken in animals. In Smith RT, Taylor JA ed: Bracken. Ecology, Land Use and Control Technology. Proc Inter Conf Bracken '85, Parthenon Publishing: 121-132, 1985.
2. Evans WC, Patel MC, Koohy Y: Acute bracken poisoning in homogastric and ruminant animals. Proc Royal Soc Edin 81B: 29-64, 1982.
3. Brown JP: A review of the genetic effects of naturally occuring flavonoids, anthraquinones and related compounds. Mutat Res 75: 243-277, 1980.
4. Pamukcu AM, Yalciner S, Hatcher JF et al: Quercetin, a rat intestinal and bladder carcinogen present in bracken fern (Pteridium aquilinum). Cancer Res 40: 3468-3472, 1980.
5. Evans IA, Osman MA: Carcinogenicity of bracken and shikimic acid. Nature (London) 250: 348-349, 1974.
6. Jones RS, Ali M, Ioannides C et al: The mutagenic and cell transforming properties of shikimic acid and some of its bacterial and mammalian metabolites. Toxicol Lett 19: 43-50, 1983.
7. Niwa H, Ojika M, Wakamatsu K et al: Ptaquiloside, a novel norsesquiterpene glucoside from bracken, Pteridium aquilinum var. Latiusculun. Tetrahedron Lett 24: 117-120, 1983.
8. Van der Hoeven JCM, Lagerweij WJ, Posthumus MA et al: Aquilide A, a new mutagenic compound isolated from bracken fern (Pteridium aquilinum L Kuhn). Carcinogenesis 4: 1587-1590, 1983.
9. Kofod H, Eyjolfsson R: The isolation of the cyanogenic glycoside prunasin from Pteridium aquilinum (L) Kuhn. Tetrahedron Lett 12: 1289-1291, 1966.
10. Wang C-Y, Chiu CW, Pamukcu AM et al: Identification of carcinogenic tannin isolated from bracken fern (Pteridium aquilinum). J Natl Cancer Inst 56: 33-36, 1976.
11. Herrmann K: Flavonols and flavones in food plants: A review. J Fd Technol 11: 433-448, 1976.
12. Kuhnau J: The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 24: 117-191, 1976.
13. Bjeldanes LF, Chang GW: Mutagenic activity of queroetin and related compounds. Science 197: 577-578, 1977.
14. MacGregor JT, Jurd L: Mutagenicity of plant flavonoids: Structural requirements for mutagenic activity in Salmonella typhimurium. Mutat Res 54: 297-309, 1978.
15. Brown JP, Dietrich PS: Mutagenicity of plant flavonols in the Salmonella mammalian microsome test. Activation of flavonol glycosides by mixed glycosidases from rat cecal bacteria and other sources. Mutat Res 66: 223-240, 1979.
16. Anacher DE, Paillet S, Ray VA: Point mutation at the thymidine kinase locus in L5178Y mouse lymphoma cells. 1. Application to genetic toxicology testing. Mutat Res 64: 391-406, 1979.
17. Maruta A, Enaka K, Umeda M: Mutagenicity of quercetin and kaempferol on cultured mammalian cells. Gann 70: 273-276, 1979.
18. Carver JH, Carrano AV, MacGregor JT: Genetic effects of the flavonols quercetin, kaempferol and galangin on Chinese hamster ovary cells in vitro. Mutat Res 113: 45-60, 1983.
19. Gold LS, Bernstein L, Magaw R et al: Interspecies extrapolation in carcinogenesis: Prediction between rats and mice. Environ Health Perspect 81: 211-219, 1989.
20. Ames BN, Gold LS: Chemical carcinogenesis. Too many rodent carcinogens. Proc Natl Acad Sci USA 87: 7772-7776, 1990.
21. Matoba M, Saito E, Saito K et al: Assay of ptaquiloside, the the carcinogenic principle of bracken, Pteridium aquilinum, by mutagenicity testing in Salmonella typhimurium. Mutagenesis 2: 419-423, 1987.
22. Hirono I, Also S, Yamaji T et al: Carcinogenicity in rats of ptaquiloside isolated from bracken. Gann 75: 833-836, 1984.
23. Hirono I, Kono Y, Takahashi K et al: Reproduction of acute bracken poisoning in a calf with ptaquiloside, a bracken constituent. Vet Rec 115: 375-378, 1984.
24. Hirono I, Ogino H, Fujimoto M et al: Induction of tumors in ACI rats given a diet containing ptaquiloside, a bracken constituent. J Natl Cancer Inst 79: 1143-1150, 1987.
25. Gillies RG, Gidier N, Denton M: Determination of cell number in monolayer cultures. Anal Biochem 159: 109-113, 1986.
26. Kueng W, Silber E, Eppenberger U: Quantitation of cells cultured on 96-well plates. Anal Biochem 182: 16-19, 1989.
27. Benford DJ, Hubbard SA: Preparation and culture of mammalian cells. In Snell K, Mullock B: Biochemical Toxicology. A Practical Approach. IRL Press Oxford: 57-79, 1987.
28. Ueno I, Kohno M, Haraikawa K et al: Interaction between quercetin and Superoxide radicals. Reduction of the quercetin mutagenicity. J Pharm Dyn 7: 798-803, 1984.
29. Hodnick WF, Kung FS, Roattger WJ et al: Inhibition of mitochondrial respiration and production of toxic oxygen radicals by flavonoids. A structure-activity study. Biochem Pharmacol 35: 2345-2357, 1986.
30. Rueff J, Laires A, Bras A et al: DNA damage and oxygen species. In Lambert MW, Laval J ed: DNA Repair Mechanisms and Their Biological Implications in Mammalian Cells. Plenum Press, New York: 171-181, 1989.
31. Fridovich I: Superoxide dismutases. Ann Rev Biochem 44: 147-159, 1975.
32. Graham DG, Tiffany SM, Bell WR Jr et al: Autoxidation versus covalent binding of qui nones as the mechanism of toxicity of dopamine, 6-hydroxydopamine and related compounds towards C1300 neuroblastoma cells in vitro. Mol Pharmacol 14: 644-653, 1978.
33. Brunmark A, Cadenas E: Redox and addition chemistry of quinoid compounds and its biological implications. Free Radical Biol Med 7: 435-477, 1989.
34. Rueff J, Laires A, Borba H et al: Genetic toxicology of flavonoids: The role of metabolic conditions in the induction of reverse mutation, SOS functions and sister-chromatid exchanges. Mutagenesis 1: 179-183, 1986.
35. Carpenedo F, Bortignon C, Bruni A et al: Effect of quercetin on membrane-linked activities. Biochem Pharmacol 18: 1495-1500, 1969.
36. +) adenosine triphosphatase and its partial reactions by quercetin. Biochemistry 15: 4951-4956, 1976.
37. 2+)-ATPase of sarcoplasmic reticulum. J Biol Chem 256: 887-892, 1981.
38. Suolinna E-M, Lang DR, Racker E: Quercetin, an artificial regulator of the high aerobic glycolysis of tumor cells. J Natl Cancer Inst 53: 1515-1519, 1974.
39. 2+ influx and exocytosis in rat peritoneal mast cells. Biochin Biophys Acta 469: 60-62, 1977.
40. Graziani Y, Chayoth R: Regulation of cyclic AMP level and synthesis of DNA, RNA and protein by quercetin in Ehrlichs ascites tumour cells. Biochem Pharmacol 28: 397-403, 1979.
41. Fiebrich F, Koch H: Silymarin, an inhibitor of lipoxygenase. Experientia 35: 1548-1550, 1975.
42. Fiebrich F, Koch H: Silymarin, an inhibitor of prostaglandin synthetase. Experientia 35: 1550-1552, 1975.
43. Baumann J, Bruchhausen FV, Wurum G: Flavonoids and related compounds as inhibitors of arachidonic acid peroxidation. Prostaglandins 20: 627-639, 1980.
44. 2+ fluxes in rabbit neutrophils. J Reticulaendothel Soc 30: 157-161, 1981.
45. Suolinna E-M, Buchsbaum RN, Racker E: The effect of flavonoids on aerobic glycolysis and growth of tumor cells. Cancer Res 35: 1865-1872, 1975.
46. Kim JH, Kim HS, Alfieri AA et al: Quercetin, an inhibitor of lactate transport and hyperthermic sensitizer of HeLa cells. Cancer Res 44: 102-106, 1984.
47. Scambia G, Ranelleti FO, Benedeti Panici P et al: Inhibitory effect of quercetin on OVCA 433 cells and presence of type II oestrogen binding sites in primary ovarian tumors and cultured cells. Br J Cancer 62: 942-946, 1990.
48. Brewster D, Jones RS, Parke DV: The metabolism of shikimate in the rat. Biochem J 170: 257-264, 1978.
49. Brewster D: The metabolism of shikimic acid. PhD Thesis, University of Surrey, Guildford, 1977.
50. Hebb CR, Chu M-YW: Reversible injury of L-strain mouse cells by trypsin. Exp Cell Ress 20: 453, 1960.
51. Waymouth C: To disaggregate or not to disaggregate: Injury and cell disaggregation, transient or permanent. In Vitro 10: 97-111, 1974.
52. Barranco SC, Bolton WE, Novak JK: Time dependent changes in drug sensitivity expressed by mammalian cells after exposure to trypsin. J Natl Cancer Inst 64: 913-916, 1980.